You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

March 9, 2026

EV Liability under Thailand’s Product Liability Law

Over the past several years, numerous automobile manufacturers have brought electric vehicles (EVs) to the market and received positive feedback from consumers in Thailand and around the world. EVs have gained popularity due to their lower maintenance costs, reduced energy expenses, and environmental benefits.

However, reports have emerged of EVs causing problems such as battery fires, autopilot malfunctions leading to accidents, and safety systems such as brakes engaging automatically under inappropriate conditions. Even when these situations do not cause injury to drivers or passengers, they raise significant concerns for EV manufacturers, importers, and sellers operating in Thailand. These problems may seriously impact businesses if the products are identified as unsafe under Thailand’s Product Liability Act (PLA), officially known as the Liability for Damages Arising from Unsafe Products Act. Under this law, authorities or courts can order business operators to recall products from the market or prohibit their export, import, or sale.

To manage and mitigate the risk of being found liable for damages due to an unsafe product under the PLA, EV business operators should be aware of the scope of the law.

Potentially Liable Parties

The PLA identifies several types of entrepreneurs and business operators—both individuals and entities—as “potentially liable parties” (PLPs) who may be held liable under the law. In the EV context, this could include vehicle manufacturers, battery suppliers, software developers whose systems are integrated into the vehicle, and local importers or distributors. Specifically, the PLA covers:

  • Manufacturers or hirers
  • Importers
  • Sellers of goods for which the manufacturer, hirer, or importer cannot be identified
  • Any other party who uses the name, trade name, trademark, or statements associated with the alleged unsafe products, or acts in a manner that causes them to be perceived as a manufacturer, hirer, or importer

Definition of “Product” and “Unsafe Product”

The PLA defines a “product” as any kind of movable property that has been manufactured or imported for sale—including agricultural products and electricity, but excluding those ruled out by ministerial regulations. EVs and their components, including battery packs and onboard software systems, fall within this definition. Real estate and services are excluded from the PLA, though real estate buyers are protected by the Civil and Commercial Code and, in some circumstances, by the Consumer Protection Act.

The PLA defines an “unsafe product” as any product that causes or may cause damage or injury due to a manufacturing defect, design defect, or lack of clear warning, instructions, or other information about usage, maintenance, or preservation of the product. For EVs, this could encompass a broad range of issues, such as a battery cell defect that creates a fire risk, an algorithmic flaw in an autopilot or automatic braking system, or insufficient warnings about charging safety or battery maintenance. If an unsafe product causes damage or injury to the consumer who purchased it, regardless of whether the damage was caused intentionally or negligently, every PLP will be jointly liable for the damages sustained by the consumer, with few exceptions.

Burden of Proof and Limitations on Liability Waivers

Under the PLA, aggrieved parties only need to prove that they suffered damage or injury from the PLP’s product and that they had used and maintained the product properly. The aggrieved party does not need to prove which PLP caused the damage or injury—a significant consideration in the EV industry, where vehicles incorporate components and software from multiple suppliers across complex international supply chains.

PLPs cannot avoid liability by entering into an agreement with the consumer that waives or limits PLPs’ liability in advance.

Defenses Available to PLPs

PLPs facing claims under the PLA can avoid liability if they can prove one of the following:

  • The product was not unsafe.
  • The plaintiff was aware that the product was unsafe.
  • The plaintiff misused the product despite clear information and warnings.

In the EV context, the third defense underscores the importance of providing consumers with thorough and accessible documentation on matters such as charging procedures, battery care, and the correct operation of assisted-driving features.

Claims and Remedies

The PLA provides two methods through which an aggrieved party can bring a claim: filing a lawsuit in court or filing a complaint with the Consumer Protection Board.

Alternatively, a foundation or association authorized by the Consumer Protection Board may file the complaint on behalf of the aggrieved consumer or party. If the foundation or association submits the complaint to the relevant court, court fees are waived, though fees ordered by the court in its final judgment remain payable.

If court determines that an aggrieved party was damaged by an unsafe product, the court will award damages. These damages are not restricted to those set out in the Civil and Commercial Code but may include other forms of compensation that are unusual under Thai law, at the court’s discretion. For example, the court may award damages for mental pain and suffering as well as actual bodily harm and harm to property. If the unsafe product caused a person’s death, the court may award damages for the mental pain and suffering of the immediate family. If the PLP was aware, or should have been aware, that the product was unsafe—or acted with gross negligence—the court may award punitive damages of up to twice the actual damages.

Administrative Enforcement

The Consumer Protection Board or the relevant court may order business operators to recall, destroy, or cease selling any unsafe product if the business operator fails to comply with the PLA’s requirements. For EV operators, a recall order could have substantial commercial consequences given the complexity and cost of EV components, making proactive compliance a sound business priority.

Outlook

Thailand’s growing EV market brings significant opportunity but also meaningful legal exposure under the PLA. The law protects consumers from unsafe products by simplifying procedures and reducing the burden on consumers seeking to bring an action, while leaving only a few avenues for PLPs to avoid liability. EV manufacturers, importers, and sellers operating in Thailand should carefully assess their potential liabilities before bringing a product to market.

RELATED INSIGHTS​ 

October 25, 2021
Michael Ramirez, a counsel in Tilleke & Gibbins’ dispute resolution group in Bangkok, has updated the firm’s contribution to the Global Attorney-Client Privilege Guide, published by Lex Mundi. The newly expanded guide provides information on what constitutes attorney-client privilege in over 70 countries around the world. The Thailand section of the guide contains in-depth information on the function and applications of attorney-client privilege in Thailand (or, as explained in the guide, an equivalent concept enshrined in Thai law), including coverage of the following topics: Privilege in corporations Common interest doctrine Litigation funding Crime-fraud exception Work product doctrine/litigation privilege Other privileges including mediation, accountant-client and settlement negotiation The interactive guide features expert contributions by Lex Mundi member firms from jurisdictions worldwide. Readers can browse the contributions, generate country-specific reports, and compare attorney-client privilege in multiple jurisdictions. For more information, please visit the Lex Mundi website.
October 14, 2021
As part of its membership in Lex Mundi, Tilleke & Gibbins has published an updated edition of its Guide to Doing Business in Thailand for 2021. This guide outlines all of the key factors for starting and operating a business in the Thai market. Issues covered include: Investment incentives Financial facilities Exchange controls Import and export regulations Structures for doing business Requirements for the Establishment of a Business Operation of the Business Cessation or Termination of the Business Labor legislation, relations, and supply Tax Immigration requirements This publication is part of Lex Mundi’s Guides to Doing Business series prepared by member firms in more than 100 jurisdictions worldwide. The guides serve as a useful resource when planning an international business strategy or researching a new market.
August 26, 2021
The Ministry of Health of Vietnam recently issued Circular No. 10/2021/TT-BYT dated June 30, 2021, stipulating the list of substances prohibited from use in the production and trading of health supplements (“Circular 10”). Circular 10 will come into effect on September 1, 2021. Accordingly, substances found on the following lists will be prohibited from use in health supplements: The list of drugs and drug materials prohibited from importation and production found in Annex V of Decree No. 54/2017/ND-CP of the Government dated May 8, 2017, guiding the implementation of Law on Pharmacy (Decree 54). Lists promulgated with Decree No. 73/2018/ND-CP of the Government dated May 15, 2018, stipulating the list of narcotic substances and precursors, including: List I: Narcotic substances banned from use in healthcare and daily life, the use of which for analysis, testing, scientific research, and criminal investigation is subject to permission by competent authorities. List II: Narcotic substances restricted from analysis, testing, scientific research, criminal investigation, or healthcare as regulated by competent authorities. List III: Narcotic substances permitted in analysis, testing, scientific research, criminal investigation, healthcare, and veterinary medicine as regulated by competent authorities. List IVA: Essential precursors involved in forming the structure of narcotic substances. The list of narcotic active ingredients found in Annex I of Circular No. 20/2017/TT-BYT of the Ministry of Health, detailing articles of the Law on Pharmacy and Decree 54 related to drugs and drug materials under special control. The list of toxic drugs and toxic drug materials under Circular No. 06/2017/TT-BYT of the Ministry of Health dated May 3, 2017. Lists under Circular No. 42/2017/TT-BYT of the Ministry of Health dated November 13, 2017, stipulating the lists of toxic herbal materials, including: Annex I: List of toxic herbal materials of plant origin. Annex II: List of toxic herbal materials of
August 26, 2021
In April 2021, the Vietnamese government made public a draft decree to amend Decree No. 43/2017/ND-CP of the Government dated April 14, 2017, on goods labeling (“Decree 43”), which is the primary legislation in Vietnam on the labeling requirements for domestically circulating goods and imported goods. Some noteworthy differences between the draft and the current Decree 43 include the following: 1. Original labels for imported products For imported goods, the draft adds a requirement on compulsory information for original labels, which is not mentioned in Decree 43. In particular, the original product label for goods being imported to circulate on the Vietnam market must contain the following compulsory information in a foreign language or in Vietnamese before customs clearance: Product name; Name and address of the entities responsible for the products; Product origin or place where the final production stage to complete the product was conducted. (If this information is not presented on the original product label, it must be included in the import documents accompanying the product.) 2. Vietnamese labels for imported products Under the draft, if it is impossible to determine the product origin under rules/guidance on determining product origin in Vietnam, it is acceptable to instead indicate on the product label the place(s) where the final production stage to complete the product was conducted. 3. Nutritional information for food Instead of being optional information as mentioned in Decree 43, “nutritional value” is compulsory information on labels for some food products under the draft. The Ministry of Health will have a roadmap for carrying out nutritional labeling and will provide appropriate guidance to manufacturers and importers, as well as issue regulations on types of food that are partially or entirely exempt from declaration of nutritional value. The draft has not yet been finalized and is subject to